Skip to main content
Top
Published in: Journal of Cancer Research and Clinical Oncology 6/2018

01-06-2018 | Review – Clinical Oncology

Quality control and improvement of cancer care: what is needed? 4th European Roundtable Meeting (ERTM) May 5th, 2017, Berlin, Germany

Authors: Olaf Ortmann, Ulrike Helbig, Julie Torode, Stefan Schreck, Sakari Karjalainen, Manola Bettio, Ulrik Ringborg, Monika Klinkhammer-Schalke, Freddy Bray, For the participants of the ERTM

Published in: Journal of Cancer Research and Clinical Oncology | Issue 6/2018

Login to get access

Abstract

Purpose

National Cancer Control Plans (NCCPs) often describe structural requirements for high quality cancer care. During the fourth European Roundtable Meeting (ERTM) participants shared learnings from their own national setting to formulate best practice in optimizing communication strategies between parties involved in clinical cancer registries, cancer centers and guideline groups.

Results

A decentralized model of data collection close to the patient and caregiver enhances timely completion and the quality of the data captured. Nevertheless, central coordination is necessary to define datasets, indicators, standard settings, education, training and quality control to maintain standards across the network. In particular, interaction of parties in cancer care network has to be established and maintained on a regular basis.

Conclusion

After establishing the structural requirements of cancer care networks, communication between the different components and parties is required to analyze outcome data, provide regular reporting to all and develop strategies for continuous improvement of quality across the network.
Literature
go back to reference Martin Moreno JM, Albrecht T, Rados Kruel S et al (2013) Boosting Innovation and cooperation in European Cancer Control: key findings from the European Partnership for Action Against Cancer (EPAAC) National Institution of Public Health of the Republic of Slovenia and World Health Organization. http://www.epaac.eu/. Accessed 11 Jan 2018 Martin Moreno JM, Albrecht T, Rados Kruel S et al (2013) Boosting Innovation and cooperation in European Cancer Control: key findings from the European Partnership for Action Against Cancer (EPAAC) National Institution of Public Health of the Republic of Slovenia and World Health Organization. http://​www.​epaac.​eu/​. Accessed 11 Jan 2018
go back to reference Ortmann O, Torode J, Helbig U (2016) Improving structural development in oncology: transformation of theoretical health care standards and knowledge into a practical approach—2nd European Roundtable Meeting (ERTM), May 8, 2015, Berlin, Germany. J Cancer Res Clin Oncol 142(4):807–811. https://doi.org/10.1007/s00432-015-2052-9 (Epub 2015 Oct 19) CrossRefPubMed Ortmann O, Torode J, Helbig U (2016) Improving structural development in oncology: transformation of theoretical health care standards and knowledge into a practical approach—2nd European Roundtable Meeting (ERTM), May 8, 2015, Berlin, Germany. J Cancer Res Clin Oncol 142(4):807–811. https://​doi.​org/​10.​1007/​s00432-015-2052-9 (Epub 2015 Oct 19) CrossRefPubMed
Metadata
Title
Quality control and improvement of cancer care: what is needed? 4th European Roundtable Meeting (ERTM) May 5th, 2017, Berlin, Germany
Authors
Olaf Ortmann
Ulrike Helbig
Julie Torode
Stefan Schreck
Sakari Karjalainen
Manola Bettio
Ulrik Ringborg
Monika Klinkhammer-Schalke
Freddy Bray
For the participants of the ERTM
Publication date
01-06-2018
Publisher
Springer Berlin Heidelberg
Published in
Journal of Cancer Research and Clinical Oncology / Issue 6/2018
Print ISSN: 0171-5216
Electronic ISSN: 1432-1335
DOI
https://doi.org/10.1007/s00432-018-2638-0

Other articles of this Issue 6/2018

Journal of Cancer Research and Clinical Oncology 6/2018 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine